Email updates

Keep up to date with the latest news and content from JTM and BioMed Central.

Open Access Research

Investigation of HIFU-induced anti-tumor immunity in a murine tumor model

Zhenlin Hu, Xiao Yi Yang, Yunbo Liu, Georgy N Sankin, Eric C Pua, Michael A Morse, H Kim Lyerly, Timothy M Clay and Pei Zhong*

Journal of Translational Medicine 2007, 5:34  doi:10.1186/1479-5876-5-34

PubMed Commons is an experimental system of commenting on PubMed abstracts, introduced in October 2013. Comments are displayed on the abstract page, but during the initial closed pilot, only registered users can read or post comments. Any researcher who is listed as an author of an article indexed by PubMed is entitled to participate in the pilot. If you would like to participate and need an invitation, please email info@biomedcentral.com, giving the PubMed ID of an article on which you are an author. For more information, see the PubMed Commons FAQ.

HIFU and potential immune response in cancer therapy

George Suarez   (2007-11-05 12:43)  International HIFU Centers email

We have been using HIFU in combination with autologous patient's Dendrite cell therapy for advanced prostate cancer with excellent outcomes. There is no doubt that the combination therapy holds great promise for advanced stage desease in prostate cancer, as well as potential other types of cancer. For more information visit www.internationalhifucenters.com

Competing interests

I am the Medical Director for the International HIFU Centers.

top

Post a comment